Novo Nordisk shares on the rise: patent lawsuit puts further pressure on Hims & Hers
The Danish pharmaceutical company Novo Nordisk is taking legal action against the US telemedicine company Hims & Hers in order to stop the distribution of unauthorized copies of semaglutide. •…
